Michael D. Clayman serves as Executive at Flexion Therapeutics Inc, where they oversee executive responsibilities. Since joining the company, Michael D. Clayman has executed 66 insider transactions totaling $968.2K, demonstrating a bullish approach to their equity position. Their most recent transaction on Dec 20, 2016 involved transacting 147 shares valued at $1.3K.
Michael D. Clayman currently holds 334,981 shares of Flexion Therapeutics Inc (FLXN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Michael D. Clayman has been a net buyer of FLXN stock. They have purchased $927.6K and sold $40.5K worth of shares.
Michael D. Clayman's most recent insider trade was on Dec 20, 2016, when they sold 147 shares at $9.01 per share.
Get notified when new Form 4 filings are submitted
| $18.41 |
| Discretionary |
| Nov 22, 2016 | FLXN | $29.9K | Purchase | 1,666 | $17.95 | Discretionary |
| Nov 21, 2016 | FLXN | $29.8K | Purchase | 1,666 | $17.90 | Discretionary |
| Jun 21, 2016 | FLXN | $0 | Gift | 15,722 | $N/A | Discretionary |
| Jun 21, 2016 | FLXN | $0 | Gift | 15,722 | $N/A | Discretionary |
| May 23, 2016 | FLXN | $1.7K | Option Exercise | 10,369 | $0.16 | Discretionary |
| May 20, 2016 | FLXN | $20.8K | Purchase | 2,000 | $10.41 | Discretionary |
| May 19, 2016 | FLXN | $19.3K | Purchase | 2,000 | $9.65 | Discretionary |
| May 18, 2016 | FLXN | $20.5K | Purchase | 2,000 | $10.23 | Discretionary |
| May 17, 2016 | FLXN | $19.5K | Purchase | 2,000 | $9.73 | Discretionary |
| May 16, 2016 | FLXN | $19.0K | Purchase | 2,000 | $9.51 | Discretionary |
| May 20, 2015 | FLXN | $21.2K | Other | 1,784 | $11.91 | Discretionary |
| Mar 24, 2015 | FLXN | $800 | Option Exercise | 5,000 | $0.16 | Discretionary |
| Nov 20, 2014 | FLXN | $21.2K | Other | 1,784 | $11.91 | Discretionary |
| Feb 18, 2014 | FLXN | $0 | Conversion | 356,703 | $N/A | Discretionary |